- Report
- February 2025
- 200 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- February 2025
- 200 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- February 2025
- 200 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- January 2025
- 175 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Drug Pipelines
- April 2025
- 400 Pages
Global
From €3525EUR$4,000USD£3,096GBP
€4406EUR$5,000USD£3,870GBP
- Report
- May 2025
- 120 Pages
Global
From €4186EUR$4,750USD£3,677GBP
- Report
- August 2025
- 154 Pages
Global
From €3481EUR$3,950USD£3,057GBP
- Report
- September 2025
- 150 Pages
Global
From €3921EUR$4,450USD£3,444GBP
- Report
- June 2025
- 142 Pages
Global
From €3481EUR$3,950USD£3,057GBP
- Report
- September 2025
- 150 Pages
Global
From €3393EUR$3,850USD£2,980GBP
- Report
- September 2025
- 150 Pages
Global
From €3393EUR$3,850USD£2,980GBP
- Report
- June 2025
- 150 Pages
Global
From €3393EUR$3,850USD£2,980GBP
€4274EUR$4,850USD£3,754GBP
- Report
- July 2025
- 350 Pages
Global
From €4361EUR$4,949USD£3,831GBP
- Report
- June 2025
- 400 Pages
Global
From €4361EUR$4,949USD£3,831GBP
- Report
- June 2025
- 400 Pages
Global
From €4361EUR$4,949USD£3,831GBP
- Report
- June 2025
- 400 Pages
Global
From €4361EUR$4,949USD£3,831GBP
- Report
- June 2025
- 400 Pages
Global
From €4361EUR$4,949USD£3,831GBP
- Report
- June 2025
- 400 Pages
Global
From €4361EUR$4,949USD£3,831GBP
- Report
- June 2025
- 400 Pages
Global
From €4361EUR$4,949USD£3,831GBP
- Report
- April 2025
- 199 Pages
Global
From €4402EUR$4,995USD£3,866GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more